Roche gets EUA in India for antibody cocktail (Casirivimab and Imdevimab) to treat COVID-19 Read more
Cipla continues to expand focus on therapy areas of promising growth through deals: GlobalData Read more
Roche’s Atezolizumab receives DCGI approval for treatment of metastatic triple-negative breast cancer in India Read more
By 2030, we want to treat one in five cancer patients in India: Lara Bezerra, MD Roche India Read more